However, Ogembo et al. demonstrated that EBV infection could occur via CD35 and HLA-DR in CD21-deficient cells [17], and these molecules have been thought to be the receptor for EBV in THP-1 cells and primary human monocytes. This evidence concerns the gene CR2 and Epstein-Barr virus infection.